Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Uses and abuses of screening tests

Grimes, David A, Schulz, Kenneth F · 2002 · The Lancet

Abstract

Screening tests are ubiquitous in contemporary practice, yet the principles of screening are widely misunderstood. Screening is the testing of apparently well people to find those at increased risk of having a disease or disorder. Although an earlier diagnosis generally has intuitive appeal, earlier might not always be better, or worth the cost. Four terms describe the validity of a screening test: sensitivity, specificity, and predictive value of positive and negative results. For tests with continuous variables--eg, blood glucose--sensitivity and specificity are inversely related; where the cutoff for abnormal is placed should indicate the clinical effect of wrong results. The prevalence of disease in a population affects screening test performance: in low-prevalence settings, even very good tests have poor predictive value positives. Hence, knowledge of the approximate prevalence of disease is a prerequisite to interpreting screening test results. Tests are often done in sequence, as is true for syphilis and HIV-1 infection. Lead-time and length biases distort the apparent value of screening programmes; randomised controlled trials are the only way to avoid these biases. Screening can improve health; strong indirect evidence links cervical cytology programmes to declines in cervical cancer mortality. However, inappropriate application or interpretation of screening tests can rob people of their perceived health, initiate harmful diagnostic testing, and squander health-care…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)07948-5

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Cited by

See all 545

Metadata

Authors
Grimes, D. A., & Schulz, K. F.
Affiliations
Family Health International 360 (US)
Corresponding author
Grimes, David A
Venue
The Lancet
Publisher
Elsevier BV
Published
2002-03
Volume
359
Issue
9309
Pages
881-884
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2002693002
Cited by
545
References
26
Citations by year
2026: 16 · 2025: 22 · 2024: 20 · 2023: 16 · 2022: 17 · 2021: 19 · 2020: 16 · 2019: 18 · 2018: 20 · 2017: 25 · 2016: 23 · 2015: 30 · 2014: 23 · 2013: 32 · 2012: 26
FWCI
10.64
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
Keywords
screening test, sensitivity and specificity, predictive value, disease prevalence, lead-time bias, length bias, cervical cancer screening, cervical cytology, syphilis screening, cost-effectiveness of screening, overdiagnosis, randomized controlled trials
MeSH terms
Ethics, Medical, False Negative Reactions, False Positive Reactions, Female, Humans, Infant, Newborn, Male, Mass Screening, Middle Aged, Predictive Value of Tests, Pregnancy, Sensitivity and Specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Uses and abuses of screening tests. https://app.cochat.ai/papers/10.1016/s0140-6736(02)07948-5
The paper
Grimes, D. A., & Schulz, K. F. (2002). Uses and abuses of screening tests. The Lancet. https://doi.org/10.1016/s0140-6736(02)07948-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.